Pros
You get a 1-hour lunch Allows for longer vacations Finally did a office refresh (was needed) Good for people looking to gain experience and move on.
Cons
There are zero meaningful Human Resource programs - Continued learning is discouraged as the lab needs everyone available all the time. No one gets to go to conferences or workshops to learn new techniques. The company didn't roll down company goals and personal objectives for 2024 (and 2025 from what I heard) and generally has no interest in personnel improvement and career planning. The lab management purchases new equipment but never installs them properly. They rarely buy the install/operation/performance qualification services because they cost extra, even though they perform clinical work and should be doing so. In the case of lab automation we bought lab management doesn't make it a priority to install and test protocols so most of the work is still done manually. Quality Assurance is a low priority, where profit is more important. Official company protocols are nonexistent, they use vendor handbooks and process decisions/guidance don't exist leading to a lot of redone work. Management hires people they can afford, not the right people for the role/job. Mngt/HR make employees clean the office since they are too cheap to hire a cleaning company. CFO and CEO continue to spend less on sales and marketing and simply hope new customers will show up. Other than the 3 Korean members of the sales team that have been there several years, that dept turns over every 1.5-2.5 years due to their frustration or CEO and CFO not seeing revenue improve - though they don't spend the money to gain more customers. 2024 was a nightmare as they brought in a new Chief Science Officer who didn't deliver and was incredibly rude to people. They tried to improve the clinical business but were never willing to invest in the change that was required and the VP left in 1 yr. Prior to Dec 2024 when Macrogen became 51% stakeholder, the mngt team was still being ruled by Macrogen who is on the other side of globe and disconnected from the US customers. And the 51% ownership may change company's ability to go after certain federal contracts as a US company that is now a majority owned by a foreign entity.